Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU213
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,640
Award facts
- Contract value 100% obligated
- $17,640.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,640.36 to AmerisourceBergen Drug Corp for KESIMPTA 20 MG/0.4 ML pen injectors on November 26, 2025, with completion expected by November 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor through its DLA prime contract vehicle. The SPE2DX IDC functions as a comprehensive global pharmaceutical support mechanism enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for KESIMPTA, a neurological medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs for Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FU213?
SPE2DR26FU213 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FU213 worth?
The government has obligated $17,640 on SPE2DR26FU213.
Is contract SPE2DR26FU213 an order under another contract?
Yes. SPE2DR26FU213 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU213 competed?
The extent of competition for SPE2DR26FU213 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award